Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.50    0.50 (0.11%)
Bid:
430.50
Ask:
445.50
Spread: 15.00 (3.484%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Pre-close Trading Statement

20 Apr 2009 07:00

RNS Number : 7777Q
Creston PLC
20 April 2009
 



 20 April 2009

Creston plc 

Pre-Close Trading Statement

Creston plc (LSE: CRE), the Insight and Communications Group, provides an update on trading prior to entering its close period in advance of the preliminary results for the year ended 31 March 2009.

In the 2009 financial year, the Company has performed ahead of consensus forecasts for revenue (achieving 4% year-on-year growth), EBIT, EBITDA, earnings per share and had a lower net debt position. 

This strong performance has been driven by an excellent new business performance that more than compensates for general market softness. Since the Interim Statement in November 2008, there have been a number of significant new business wins across the Group from both existing and new clients. These wins include Astellas, Boehringer Ingelheim, E-ON, GSK, Marie Curie Cancer Care, Panasonic, Spicers and Toyota. Net new business wins for the year will generate over £15 million in revenue (2008: £9 million). The Group continues to have a healthy pipeline of new business, especially in digital and on-line research. 

All acquired Group companies have completed their earn-out periods by 31 March 2009 and the final deferred consideration, which can now be finalised and is no longer contingent upon future profit levels, will be detailed in the preliminary announcement and will be settled in December 2009 and June 2010. 

At 31 March 2009, net debt was approximately £19 million having been reduced by over £12 million since September 2008, after a strong cash generating performance during the second half of the financial year. This reduction in net debt also follows the settlement of over £13 million deferred consideration in respect of DLKW.

The Group maintained tight management of its key performance indicators covering revenue and profit per head and operating profit margin. Consequently the Group ends the year with operating costs aligned to revenues forecast for the new financial year.

Creston plc expects to announce its preliminary results for the year ended 31 March 2009 on Tuesday, 23 June 2009.

-Ends- 

  

Enquiries: 

Creston plc

www.creston.com 

Don Elgie, Chief Executive

020 7930 9757

Barrie Brien, COO/CFO

Hogarth Partnership Limited

020 7357 9477

Chris Matthews / Fiona Noblet/ 

Anthony Arthur

Investec Bank (UK) Limited 

Erik Anderson/Ben Poynter

020 7597 5145

NOTES TO EDITORS:

Publication quality photographs are available through Hogarth on the numbers shown above.

About Creston plc

Since its inception in 2001, Creston has brought 10 leading brands under one roof in the UK, offering a host of blue-chip clients a range of services spanning advertising, public relations, digital marketing, market research, direct marketing and customer relationship marketing (CRM), among many others.

Creston is divided into two divisions: Insight, which encompasses those agencies engaged in understanding consumer behaviour, attitudes and needs, via research and evaluation; and Communications, which comprises agencies involved in influencing, shaping and changing consumer behaviours, attitudes and needs - this includes PR, advertising and marketing. Both divisions are entirely complementary.

Creston's share price is quoted on the London Stock Exchange under the symbol CRE and is published in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUUAPCUPBGCM
Date   Source Headline
22nd Jul 20244:51 pmRNSNotice of Results
12th Jul 20246:21 pmRNSHolding(s) in Company
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
12th Jun 202412:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSDirector/PDMR Shareholding
23rd May 20243:26 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSHolding(s) in Company
23rd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
22nd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
17th May 20244:21 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSResult of AGM
15th May 20247:00 amRNSQ1 Trading Update
15th May 20247:00 amRNSDirectorate Change
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.